Cited by 233Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCardiovascular and Diving-Related Complications

Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention

Engdahl, Johan, Andersson, Lisbeth, Mirskaya, Maria, Rosenqvist, Mårten·2013·Circulation

Abstract

Background—: Atrial fibrillation (AF) is a frequent source of cardiac emboli in patients with ischemic stroke. AF may be asymptomatic and therefore undiagnosed. Screening for silent AF seems suitable in risk populations, however little is known on the yield and cost-effectiveness of such screening. Methods and Results—: All inhabitants in the municipality of Halmstad, Sweden aged 75 to 76 years were invited to a stepwise screening program for AF. As a first step, participants recorded a 12-lead ECG and reported their relevant medical history. Those with sinus rhythm on 12-lead ECG, no history of AF, and ≥2 risk factors according to CHADS 2 were invited to a 2-week recording period using a hand-held ECG and asked to record 20 or 30 seconds twice daily and if palpitations occurred. One thousand, three hundred thirty inhabitants were invited, of whom 848 (64%) participated. Previously undiagnosed silent AF was found in 10 (1%) among 848 individuals who recorded 12-lead ECG. Among 81 patients with known AF, 35 (43%) were not on oral anticoagulation treatment. Among 403 persons with ≥2 risk factors for stroke, who completed the hand-held ECG event recording, 30 (7.4%) were diagnosed with paroxysmal AF. Thus 75/848 (9%) of the screened population were candidates for new oral anticoagulation treatment, of those 57 actually started oral anticoagulation treatment. Conclusions—: Stepwise risk factor–stratified AF screening in a 75-year-old population yields a large share of candidates for oral anticoagulation treatment on AF indication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.112.126656

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534-1539.
  2. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C. Valida- tion of risk stratification schemes for predicting stroke and thromboem- bolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
  3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
  4. Patten M, Maas R, Karim A, Müller HW, Simonovsky R, Meinertz T. Event-recorder monitoring in the diagnosis of atrial fibrillation in symp- tomatic patients: subanalysis of the SOPAT trial. J Cardiovasc Electro- physiol. 2006;17:1216-1220.
  5. Roche F, Gaspoz JM, Da Costa A, Isaaz K, Duverney D, Pichot V, Costes F, Lacour JR, Barthélémy JC. Frequent and prolonged asymptomatic epi- sodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol. 2002;25:1587-1593.
  6. Nergårdh A, Frick M. Perceived heart rhythm in relation to ECG find- ings after direct current cardioversion of atrial fibrillation. Heart. 2006;92:1244-1247.
  7. Indredavik B, Rohweder G, Lydersen S. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med. 2005;258:133-144.
  8. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32:2333-2337.
  9. Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, Velt- kamp R. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis. 2011;32:276-282.
  10. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Rad- ford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
  11. Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hos- pital detection of silent atrial fibrillation episodes. Scand Cardiovasc J. 2009;43:163-168.
  12. Doliwa Sobocinski P, Anggårdh Rooth E, Frykman Kull V, von Arbin M, Wallén H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace. 2012;14:1112-1116.
  13. Tveit A, Abdelnoor M, Enger S, Smith P. Atrial fibrillation and antithrom- botic therapy in a 75-year-old population. Cardiology. 2008;109:258-262.
  14. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, Raf- tery JP, Bryan S, Davies M, Lip GY, Allan TF. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335:383.
  15. Alhadramy O, Jeerakathil TJ, Majumdar SR, Najjar E, Choy J, Saqqur M. Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke. 2010;41:2596-2600.
  16. Tagawa M, Takeuchi S, Chinushi M, Saeki M, Taniguchi Y, Nakamura Y, Ohno H, Kitazawa K, Aizawa Y. Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cere- bral embolism. Pacing Clin Electrophysiol. 2007;30:1121-1128.
  17. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrilla- tion: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31:967-975.
  18. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Con- nolly SJ; ACTIVE W Investigators. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Car- diol. 2007;50:2156-2161.
  19. Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation. 2011;124:477-486.
  20. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43:2689-2694.
  21. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-2429.
  22. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. War- farin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927-934.
  23. Waldo AL, Becker RC, Tapson VF, Colgan KJ; NABOR Steering Com- mittee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46:1729-1736.
  24. Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J. 2008;156:57-64.
  25. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the inci- dence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011;13:1110-1117.
  26. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart. 1998;79:50-55.
  27. Ericson L, Bergfeldt L, Björholt I. Atrial fibrillation: the cost of illness in Sweden. Eur J Health Econ. 2011;12:479-487.
  28. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Dea- ton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Kn- uuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Ver- heugt FW; ESC Committee for Practice Guidelines (CPG); Document Re- viewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the manage- ment of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
  29. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Useful- ness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647-1651.
  30. Rizos T, Rasch C, Jenetzky E, Hametner C, Kathoefer S, Reinhardt R, Hepp T, Hacke W, Veltkamp R. Detection of paroxysmal atrial fibrillation in acute stroke patients. Cerebrovasc Dis. 2010;30:410-417.
  31. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B, Mende M, Wohlfahrt J, Kermer P, Vollmann D, Hasenfuss G, Gröschel K, Wachter R. Enhanced detection of paroxysmal atrial fibrillation by ear- ly and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010;41:2884-2888.
  32. Wanhainen A, Svensjö S, Tillberg M, Mani K, Björck M. [Abdominal aortic aneurysm screening in Uppsala. Good experiences from the first four years-the rest of Sweden on its way]. Lakartidningen. 2010;107: 2232-2236.

Cited by

Sorted by citations

Authors
Engdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M.
Affiliations
Danderyds sjukhus (SE)
Venue
Circulation
Published
2013-02-26
Volume
127
Issue
8
Pages
930-937
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2055181085
Cited by
233
References
10
Citations by year
2026: 4 · 2025: 9 · 2024: 5 · 2023: 10 · 2022: 14 · 2021: 32 · 2020: 16 · 2019: 18 · 2018: 22 · 2017: 15 · 2016: 21 · 2015: 23 · 2014: 23 · 2013: 21
FWCI
19.95
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Keywords
atrial fibrillation, silent atrial fibrillation, CHADS2 score, oral anticoagulation, stroke prevention, event recording, 12-lead ECG, asymptomatic atrial fibrillation, older adults, cost-effectiveness
MeSH terms
Age Factors, Aged, Atrial Fibrillation, Female, Humans, Male, Mass Screening, Population Surveillance, Risk Factors, Sweden, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review